Sensus Healthcare, Inc. (SRTS) At $5.37 Forms Top; Endurant Capital Management LP Trimmed Healthsouth (HLS) Position By $450,800

Sensus Healthcare, Inc. (SRTS) formed multiple top with $5.69 target or 6.00% above today’s $5.37 share price. Sensus Healthcare, Inc. (SRTS) has $72.41 million valuation. The stock decreased 3.02% or $0.167 during the last trading session, reaching $5.368. About 3,667 shares traded. Sensus Healthcare, Inc. (NASDAQ:SRTS) has 0.00% since January 31, 2017 and is . It has underperformed by 16.70% the S&P500.

Endurant Capital Management Lp decreased Healthsouth Corp (HLS) stake by 31.01% reported in 2017Q3 SEC filing. Endurant Capital Management Lp sold 9,800 shares as Healthsouth Corp (HLS)’s stock rose 9.48%. The Endurant Capital Management Lp holds 21,804 shares with $1.01 million value, down from 31,604 last quarter. Healthsouth Corp now has $4.86B valuation. The stock increased 0.20% or $0.1 during the last trading session, reaching $49.41. About 406,041 shares traded. Encompass Health Corporation (NYSE:HLS) has risen 15.04% since January 31, 2017 and is uptrending. It has underperformed by 1.66% the S&P500.

Analysts await Sensus Healthcare, Inc. (NASDAQ:SRTS) to report earnings on February, 1. After $-0.07 actual EPS reported by Sensus Healthcare, Inc. for the previous quarter, Wall Street now forecasts 14.29% negative EPS growth.

Analysts await Encompass Health Corporation (NYSE:HLS) to report earnings on February, 20. They expect $0.66 earnings per share, down 8.33% or $0.06 from last year’s $0.72 per share. HLS’s profit will be $64.89 million for 18.72 P/E if the $0.66 EPS becomes a reality. After $0.66 actual earnings per share reported by Encompass Health Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since August 3, 2017, it had 0 insider purchases, and 1 insider sale for $972,875 activity. Shares for $962,694 were sold by Tarr Mark J.

Endurant Capital Management Lp increased Boston Scientific Corp (NYSE:BSX) stake by 82,800 shares to 210,498 valued at $6.14M in 2017Q3. It also upped Davita Inc (NYSE:DVA) stake by 88,726 shares and now owns 274,223 shares. Entellus Med Inc was raised too.

Among 15 analysts covering Healthsouth (NYSE:HLS), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. Healthsouth had 32 analyst reports since July 31, 2015 according to SRatingsIntel. Mizuho maintained it with “Buy” rating and $47 target in Friday, April 29 report. RBC Capital Markets maintained the stock with “Buy” rating in Monday, October 9 report. RBC Capital Markets maintained it with “Outperform” rating and $48 target in Monday, October 31 report. The company was maintained on Wednesday, July 5 by RBC Capital Markets. The stock of Encompass Health Corporation (NYSE:HLS) has “Buy” rating given on Thursday, November 2 by Mizuho. On Friday, July 31 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Wednesday, January 4 the stock rating was initiated by Piper Jaffray with “Neutral”. Robert W. Baird maintained the stock with “Buy” rating in Friday, September 1 report. The stock has “Neutral” rating by Mizuho on Wednesday, November 9. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, February 27.